Biologics Regulatory Bioventus Agrees to Nationwide Contract with Aetna™ Medicare Advantage Plans for DUROLANE® for Knee Osteoarthritis byJosh SandbergDecember 7, 2023
Biologics Extremities Bioventus Reaches Milestone with 2 Million DUROLANE® Treatments Worldwide byChris StewartSeptember 22, 2020
Biologics Extremities Bioventus Selects Bazis NN as Distributor of DUROLANE® in Russia byChris StewartJune 15, 2020
Biologics Bioventus Agrees to Nationwide Contract with UnitedHealthcare® Commercial Plans byJosh SandbergSeptember 9, 2019
Biologics Bioventus Launches DUROLANE® SJ (1mL) in Australia and New Zealand; Receives Expanded Indications for DUROLANE (3mL) byJosh SandbergAugust 12, 2019
Biologics Bioventus Launches DUROLANE® in Malaysia and Selects Athrotech as Exclusive Distribution Partner byJosh SandbergJanuary 29, 2019
Hospitals Bioventus Receives ANVISA Approval to Market DUROLANE® in Brazil and Selects Pfizer as Exclusive Distribution Partner byJosh SandbergOctober 2, 2018
Biologics Bioventus Selects MEDSERVICE to Distribute DUROLANE® in Russia byJosh SandbergJanuary 17, 2017
Biologics Bioventus Launches DUROLANE® for Osteoarthritis Patients in Taiwan byJosh SandbergJanuary 6, 2016
